Last reviewed · How we verify

NCT04092699

CBCT Segmentation in Volumetric Measurements of MS Using Different Soft Wares: A Validity and Reliability Study

Status unknown NA Last updated 17 September 2019
What this trial tests

NA trial testing semiautomatic software in Sinus Volume in 10 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
1 June 2020
1 September 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingsingle
Primary purposedevice feasibility
Enrollment10
Start date1 October 2019
Primary completion1 June 2020
Estimated completion1 September 2020

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Eligibility, any sex, with Sinus Volume or CBCT Segmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cone Beam Computed Tomography (CBCT) has been used to assess the volume of the maxillary sinus using the manual and semi-automatic segmentation. The majority of researches stressed on the reduced accuracy of the automatic segmentation when compared to the real volume. Regarding the semi-automatic segmentation, there are researches assessed the volumetric measurement of the maxillary sinus and they reported that there is no significant difference between semi- automatic and the manual segmentation in CT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04092699.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing